On Thursday, February 4th, the Office of Infectious Disease and HIV/AIDS Policy (OIDP) held the first Live with LeadershipExit Disclaimer conversation of 2021 with an exciting recap from the HIV Research for Prevention ConferenceExit Disclaimer (HIV R4P). Dr. Carl Dieffenbach, Director of the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health joined Harold Phillips, Chief Operating Officer for Ending the HIV Epidemic (EHE) and Senior HIV Advisor for OIDP to discuss conference highlights and how the latest research can help us end HIV in the United States.

Harold Phillips moderated the sessionExit Disclaimer, which featured a discussion of new research released at the HIV R4P conference including information on an ever-growing field of choices for people with HIV and those looking to protect themselves from HIV. Dr. Dieffenbach also addressed the effects of COVID-19 for people living with HIV and its effects on the HIV research portfolio. He also addressed information regarding vaccines for COVID-19 during the Q&A session featuring questions asked by viewers via chat.

Live with Leadership: Continuing in 2021

The Live with Leadership series conversations provide community opportunities to hear directly from key HHS and HIV community leaders about new and ongoing work to further the goals of the EHE and the National HIV Strategic Plan. In 2020, the series included conversations held during AIDS 2020Exit Disclaimer, the National 2020 National Ryan White Conference on HIV Care and TreatmentExit Disclaimer,  the U.S. Conference on HIV/AIDS (USCHA)Exit Disclaimer and a special World AIDS DayExit Disclaimer edition. Conversations in this series are approximately 30 minutes in length and a great way to hear about EHE and key findings from HIV conferences. Look for more details soon about upcoming Live with Leadership Sessions.

To receive timely updates on upcoming Live with Leadership sessions and more from HIV.gov, follow our social media channels (FacebookExit Disclaimer, TwitterExit Disclaimer, and InstagramExit Disclaimer) and sign up for updates.